Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Customizing treatment to patient populations.

Nature clinical practice. Gastroenterology & hepatology - 1 Jan 2007

Brown Robert S

Abstract excerpt

Combination treatment with pegylated interferon plus ribavirin is the most effective therapy for patients with chronic hepatitis C virus (HCV); however, responses are less than optimal in some subpopulations of patients. Emerging insights are suggesting that viral kinetics can be used to predict...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ribavirin
Share to Viral Load
Share to Polyethylene Glycols

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Body Weight

Share to Drug Therapy, Combination

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Interferon alpha-2

Source

Identifiers

PMID: 17235282
DOI: 10.1038/ncpgasthep0693

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17235282-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Customizing treatment to patient populations.PMID 17235282Read ↗

Individualisation of antiviral therapy for chronic hepatitis C.Semantic proximity Read ↗

Pegylated interferon fractal pharmacokinetics: individualized dosing for hepatitis C virus infection.Semantic proximity Read ↗

Individualization of antiviral treatment regimens for chronic hepatitis C.Semantic proximity Read ↗

Optimizing treatment regimens in hepatitis C.Semantic proximity Read ↗

Tailoring the length of antiviral treatment for hepatitis C.Semantic proximity Read ↗

How to optimize HCV therapy in genotype 2 patients.Semantic proximity Read ↗

A simple rule to personalize standard dual therapy across all genotypes in naive chronic hepatitis C patients: the TT4 randomized trial.Semantic proximity Read ↗

Optimizing ribavirin dosage: a new challenge to improve treatment efficacy in genotype 1 hepatitis C patients.Semantic proximity Read ↗

Chronic hepatitis C therapy: changing the rules of duration.Semantic proximity Read ↗

Improved responses to pegylated interferon alfa-2b and ribavirin by individualizing treatment for 24-72 weeks.Semantic proximity Read ↗

How to optimize current treatment of genotype 2 hepatitis C virus infection.Semantic proximity Read ↗

Update on the treatment of patients with non-genotype 1 hepatitis C virus infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.